Spineart is pleased to announce the arrival of Dr. Alex Moussa as Chief Operating Officer, effective November 11th, 2019. Alex is a senior Executive Leader in the Medical devices industry, with a PhD in Pharmaceutical Sciences and a track record of success in building new business ventures, accelerating growth and in reinvigorating mature businesses. Alex spent the last 17 years at Medtronic where he led regional business units in diabetes, spine, biopharma and cardiology before serving as Vice President and President of Kanghui Orthopedics in China and VP of Cardiac Rhythm & Heart Failure in EMEA.
« Attracting a professional of the calibre and experience of Alex to the key role of COO is a testament to the commitment of Spineart to sustained growth and success. We are delighted to welcome him to Spineart » said Stéphane Mugnier-Jacob, Co-CEO & Co-Founder of Spineart.
Alex added “I’m thrilled to join such a dynamic and talented team that has made this company one of the most innovative challengers in the spine industry.”
About Spineart
Spineart is a privately held medical device company focused on simplifying the surgical act by designing, developing and promoting safe and efficient solutions to spine surgeons, operating room teams, and patients.
Spineart is a pioneer in its field, having introduced unique technologies in the fields of Minimally Invasive Surgery, Motion Preservation, Fusion, Biologics, and Fractures Treatment.
Spineart markets a complete portfolio combining traceable barcoded sterile packed implants with compact instrument sets, thus proudly promoting greater safety, cost-efficiency, and compliance at the hospital. In every enhancement, Spineart is relentlessly driven by the same philosophy: Quality, Innovation, Simplicity.